HER2-positive

35 drugs in development·17 companies·1 clinical trial

Drug Pipeline by Phase

Approved(5)

Drug	Company
MARGENZA	MACROGENICS INC (MGNX)
menacalc	METASTAT, INC. (MTST)
tukysa	Seagen Inc. (SGEN)
ziihera	Zymeworks Inc. (ZYME)
Ziihera	Jazz Pharmaceuticals plc (JAZZ)

Phase 3(16)

Drug	Company
arx788	Ambrx Biopharma Cayman, Inc. (AMAM)
bl-m07d1	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
bl-m07d1	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Datopotamab Deruxtecan	Merus N.V. (MRUS)
Eribulin	Jazz Pharmaceuticals plc (JAZZ)
Hormone Therapy	Filana Therapeutics Inc. (FLNA)
pertuzumab	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
pertuzumab	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Pertuzumab	Merus N.V. (MRUS)
Pertuzumab	ASTRAZENECA PLC (AZN)
Pertuzumab IV	Filana Therapeutics Inc. (FLNA)
t-dm1	PFIZER INC (PFE)
T-DM1	BioNTech SE (BNTX)
Taxane	ASTRAZENECA PLC (AZN)
Tucatinib	ENANTA PHARMACEUTICALS INC (ENTA)
Vinorelbine	Jazz Pharmaceuticals plc (JAZZ)

Phase 2(4)

Drug	Company
Ifinatamab Deruxtecan	Merus N.V. (MRUS)
Patritumab Deruxtecan	Merus N.V. (MRUS)
Pertuzumab	Jazz Pharmaceuticals plc (JAZZ)
RO7771950	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 1(8)

Drug	Company
elvn-002	Enliven Therapeutics, Inc. (ELVN)
eribulin	Enliven Therapeutics, Inc. (ELVN)
leucovorin	Enliven Therapeutics, Inc. (ELVN)
pepinemab	GH Research PLC (GHRS)
Pertuzumab Injection	BioNTech SE (BNTX)
Ritonavir	BioNTech SE (BNTX)
xmt-2056	Day One Biopharmaceuticals, Inc. (DAWN)
Zanidatamab	Jazz Pharmaceuticals plc (JAZZ)

Unknown(1)

Drug	Company
b-cell lymphoma 2 protein inhibitor	GH Research PLC (GHRS)

Phase 1/Phase 2(1)

Drug	Company
Itraconazole	BioNTech SE (BNTX)

BioSniper tracks 35 drugs in development for HER2-positive across 17 companies.

There are 1 clinical trial targeting HER2-positive tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.